Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 39 holding rows worth $198,330,000.

Accession
0001420506-19-000842
Filed
2019-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 39 entries on the cover page, a total value of $198,330,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $198,330,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock164,619$19,382,000thousands by filing date
Bristol-Myers Squibb Company110122108COM410,490$18,616,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock867,810$17,087,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A124,965$11,790,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM400,000$9,808,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW164,300$9,633,000thousands by filing date
HANGER INC41043F208COMMON STOCK491,685$9,416,000thousands by filing date
UNIQURE NVN90064101SHS120,000$9,378,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK260,928$9,378,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK253,327$8,167,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD2,546,997$7,972,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM369,048$7,222,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM450,000$6,692,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock126,500$6,634,000thousands by filing date
Cigna Corporation125523100COM31,227$4,920,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM51,200$4,385,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM697,921$4,188,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM547,092$4,032,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS815,789$3,541,000thousands by filing date
AC IMMUNE SAH00263105SHS563,900$3,130,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM200,000$2,698,000thousands by filing date
TELIGENT INC NEW87960W104COM2,967,721$1,870,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM6,500$1,853,000thousands by filing date
EVERFORTH INC COM00191U102Stock30,000$1,818,000thousands by filing date
EXACT SCIENCES CORP30063P955PUT14,100$1,664,000thousands by filing dateput
MOLECULAR TEMPLATES INC608550109COM197,681$1,651,000thousands by filing date
EVOLUS INC30052C107COM112,590$1,646,000thousands by filing date
PERSONALIS INC71535D106COMMON STOCK56,446$1,533,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM2,681,618$1,502,000thousands by filing date
UROVANT SCIENCESG9381B108COMMON STOCK142,620$1,128,000thousands by filing date
ARQULE INC04269E107COM83,675$921,000thousands by filing date
MILLENDO THERAPEUTICS INC60040X103COM73,868$854,000thousands by filing date
PROVIDENCE SVC CORP743815102COM14,677$842,000thousands by filing date
ADMA BIOLOGICS INC000899104COM185,721$719,000thousands by filing date
NEVRO CORP64157F103COM11,000$713,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock8,600$671,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock358,963$603,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM34,224$264,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM3,637$9,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-19-000842this filing2019-08-14acceptance time not in the bulk data set